世界のニューロトロフィン市場予測（～2028年）：神経成長因子、脳由来神経栄養因子、デヒドロエピアンドロステロン硫酸塩、その他

• 英文タイトル：Global Neurotrophins Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8903 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ニューロトロフィン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のニューロトロフィンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ニューロトロフィン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・神経成長因子、脳由来神経栄養因子、デヒドロエピアンドロステロン硫酸塩、その他 用途別セグメントは次のように区分されます。 ・アルツハイマー病、筋萎縮性側索硬化症、パーキンソン病、その他 世界のニューロトロフィン市場の主要な市場プレーヤーは以下のとおりです。 ・Johnson＆Johnson、Lonza Groups、FibroGen、Scil Proteins GmbH、Merck Serono、Scil Proteins GmbH、PeproTech、GE Healthcare 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ニューロトロフィン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なニューロトロフィンメーカーの企業概要、2019年～2022年までのニューロトロフィンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なニューロトロフィンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ニューロトロフィンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのニューロトロフィンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのニューロトロフィン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびニューロトロフィンの産業チェーンを掲載しています。 ・第13、14、15章では、ニューロトロフィンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Johnson＆Johnson、Lonza Groups、FibroGen、Scil Proteins GmbH、Merck Serono、Scil Proteins GmbH、PeproTech、GE Healthcare ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：神経成長因子、脳由来神経栄養因子、デヒドロエピアンドロステロン硫酸塩、その他 ・用途別分析2017年-2028年：アルツハイマー病、筋萎縮性側索硬化症、パーキンソン病、その他 ・ニューロトロフィンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ニューロトロフィンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ニューロトロフィンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ニューロトロフィンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ニューロトロフィンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Neurotrophins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Neurotrophins market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Alzheimer’S Disease accounting for % of the Neurotrophins global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Nerve Growth Factor segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Neurotrophins include Johnson＆Johnson, Lonza Groups, FibroGen, Scil Proteins GmbH, and Merck Serono, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Neurotrophins market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Nerve Growth Factor
Brain-Derived Neurotrophic Factor
Dehydroepiandrosterone Sulfate
Other
Market segment by Application can be divided into
Alzheimer’S Disease
Amyotrophic Lateral Sclerosis
Parkinson’S Disease
Other
The key market players for global Neurotrophins market are listed below:
Johnson＆Johnson
Lonza Groups
FibroGen
Scil Proteins GmbH
Merck Serono
Scil Proteins GmbH
PeproTech
GE Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurotrophins product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neurotrophins, with price, sales, revenue and global market share of Neurotrophins from 2019 to 2022.
Chapter 3, the Neurotrophins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurotrophins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Neurotrophins market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurotrophins.
Chapter 13, 14, and 15, to describe Neurotrophins sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Neurotrophins Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neurotrophins Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Nerve Growth Factor
1.2.3 Brain-Derived Neurotrophic Factor
1.2.4 Dehydroepiandrosterone Sulfate
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Neurotrophins Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Alzheimer’S Disease
1.3.3 Amyotrophic Lateral Sclerosis
1.3.4 Parkinson’S Disease
1.3.5 Other
1.4 Global Neurotrophins Market Size & Forecast
1.4.1 Global Neurotrophins Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Neurotrophins Sales in Volume (2017-2028)
1.4.3 Global Neurotrophins Price (2017-2028)
1.5 Global Neurotrophins Production Capacity Analysis
1.5.1 Global Neurotrophins Total Production Capacity (2017-2028)
1.5.2 Global Neurotrophins Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neurotrophins Market Drivers
1.6.2 Neurotrophins Market Restraints
1.6.3 Neurotrophins Trends Analysis
2 Manufacturers Profiles
2.1 Johnson＆Johnson
2.1.1 Johnson＆Johnson Details
2.1.2 Johnson＆Johnson Major Business
2.1.3 Johnson＆Johnson Neurotrophins Product and Services
2.1.4 Johnson＆Johnson Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Lonza Groups
2.2.1 Lonza Groups Details
2.2.2 Lonza Groups Major Business
2.2.3 Lonza Groups Neurotrophins Product and Services
2.2.4 Lonza Groups Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 FibroGen
2.3.1 FibroGen Details
2.3.2 FibroGen Major Business
2.3.3 FibroGen Neurotrophins Product and Services
2.3.4 FibroGen Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Scil Proteins GmbH
2.4.1 Scil Proteins GmbH Details
2.4.2 Scil Proteins GmbH Major Business
2.4.3 Scil Proteins GmbH Neurotrophins Product and Services
2.4.4 Scil Proteins GmbH Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck Serono
2.5.1 Merck Serono Details
2.5.2 Merck Serono Major Business
2.5.3 Merck Serono Neurotrophins Product and Services
2.5.4 Merck Serono Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Scil Proteins GmbH
2.6.1 Scil Proteins GmbH Details
2.6.2 Scil Proteins GmbH Major Business
2.6.3 Scil Proteins GmbH Neurotrophins Product and Services
2.6.4 Scil Proteins GmbH Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 PeproTech
2.7.1 PeproTech Details
2.7.2 PeproTech Major Business
2.7.3 PeproTech Neurotrophins Product and Services
2.7.4 PeproTech Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Neurotrophins Product and Services
2.8.4 GE Healthcare Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Neurotrophins Breakdown Data by Manufacturer
3.1 Global Neurotrophins Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Neurotrophins Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Neurotrophins
3.4 Market Concentration Rate
3.4.1 Top 3 Neurotrophins Manufacturer Market Share in 2021
3.4.2 Top 6 Neurotrophins Manufacturer Market Share in 2021
3.5 Global Neurotrophins Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Neurotrophins Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neurotrophins Market Size by Region
4.1.1 Global Neurotrophins Sales in Volume by Region (2017-2028)
4.1.2 Global Neurotrophins Revenue by Region (2017-2028)
4.2 North America Neurotrophins Revenue (2017-2028)
4.3 Europe Neurotrophins Revenue (2017-2028)
4.4 Asia-Pacific Neurotrophins Revenue (2017-2028)
4.5 South America Neurotrophins Revenue (2017-2028)
4.6 Middle East and Africa Neurotrophins Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Neurotrophins Sales in Volume by Type (2017-2028)
5.2 Global Neurotrophins Revenue by Type (2017-2028)
5.3 Global Neurotrophins Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Neurotrophins Sales in Volume by Application (2017-2028)
6.2 Global Neurotrophins Revenue by Application (2017-2028)
6.3 Global Neurotrophins Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Neurotrophins Sales by Type (2017-2028)
7.2 North America Neurotrophins Sales by Application (2017-2028)
7.3 North America Neurotrophins Market Size by Country
7.3.1 North America Neurotrophins Sales in Volume by Country (2017-2028)
7.3.2 North America Neurotrophins Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Neurotrophins Sales by Type (2017-2028)
8.2 Europe Neurotrophins Sales by Application (2017-2028)
8.3 Europe Neurotrophins Market Size by Country
8.3.1 Europe Neurotrophins Sales in Volume by Country (2017-2028)
8.3.2 Europe Neurotrophins Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Neurotrophins Sales by Type (2017-2028)
9.2 Asia-Pacific Neurotrophins Sales by Application (2017-2028)
9.3 Asia-Pacific Neurotrophins Market Size by Region
9.3.1 Asia-Pacific Neurotrophins Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Neurotrophins Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Neurotrophins Sales by Type (2017-2028)
10.2 South America Neurotrophins Sales by Application (2017-2028)
10.3 South America Neurotrophins Market Size by Country
10.3.1 South America Neurotrophins Sales in Volume by Country (2017-2028)
10.3.2 South America Neurotrophins Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neurotrophins Sales by Type (2017-2028)
11.2 Middle East & Africa Neurotrophins Sales by Application (2017-2028)
11.3 Middle East & Africa Neurotrophins Market Size by Country
11.3.1 Middle East & Africa Neurotrophins Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Neurotrophins Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Neurotrophins and Key Manufacturers
12.2 Manufacturing Costs Percentage of Neurotrophins
12.3 Neurotrophins Production Process
12.4 Neurotrophins Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Neurotrophins Typical Distributors
13.3 Neurotrophins Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---